# Urokinase Therapy in Diabetic Foot Syndrome

> **NCT00537498** · PHASE2 · COMPLETED · sponsor: **medac GmbH** · enrollment: 77 (actual)

## Conditions studied

- Diabetic Foot
- Arterial Occlusive Disease
- Ischemia

## Interventions

- **DRUG:** Urokinase

## Key facts

- **NCT ID:** NCT00537498
- **Lead sponsor:** medac GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2010-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537498, "Urokinase Therapy in Diabetic Foot Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00537498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*